(2026). Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial. Journal of Diabetes Investigation.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Sodium Zirconium Cyclosilicate Compared with Potassium Restriction for Hyperkalemia Management in Type 2 Diabetes: The SILVERSTAR Trial."
Journal of Diabetes Investigation 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Sodium Zirconium Cyclosilicate Compared with Potassium Restriction for Hyperkalemia Management in Type 2 Diabetes: The SILVERSTAR Trial."
Journal of Diabetes Investigation, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.